Stroke rehabilitation is a comprehensive and multidisciplinary approach aimed at helping individuals recover and regain functional independence after experiencing a stroke. Stroke, which occurs when blood flow to the brain is interrupted, can result in a range of physical, cognitive, and emotional challenges. Rehabilitation begins shortly after the acute phase of a stroke and continues throughout the recovery process. Physical therapists work on improving motor skills and mobility, occupational therapists focus on enhancing daily living activities, and speech therapists address communication and swallowing difficulties. Additionally, rehabilitation may involve psychological support to manage emotional challenges and neuropsychological interventions to address cognitive impairments. The goal of stroke rehabilitation is to maximize a person's quality of life, minimize disability, and promote their return to as independent a life as possible. The approach is individualized, considering the unique needs and abilities of each stroke survivor, and often involves a combination of therapies, assistive devices, and ongoing support from healthcare professionals and caregivers.
Title : New mechanisms and innovative therapeutics for pulmonary hypertension
Yong Xiao Wang, Albany Medical Center, United States
Title : STEMI versus acute occlusive myocardial infarction: Which term should we use?
Yochai Birnbaum, Baylor College of Medicine, United States
Title : Beyond weight loss and diabetes control GLP 1 agonists paradigm shift in Cardiovascular care .
Syed Raza, Awali Hospital, Bahrain
Title : CARDIAC TROPONIN AND HOMOCYSTEINE LEVELS IN HEMODIALYSIS PATIENTS: ASSOCIATION WITH DIALYSIS VINTAGE AND CARDIOVASCULAR COMORBIDITY
Sofra Maria, Aretaieion University Hospital, Greece
Title : New recommendations for the prevention of sudden cardiac death in athletes and recreational sports
Sekib Sokolovic, ASA Hospital Sarajevo, Bosnia and Herzegowina
Title : Coronary revascularization in patients with diabetes: Prospects for stenting in patients with type 1 diabetes and coronary artery disease
Mekhman N Mamedov, National Research Center for Therapy and Preventive Medicine, Russian Federation